Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

Mankind Pharma to absorb Bharat Serums via liquidation

PRIVATESep 13, 2026about 2 hours ago

Acquiring Company

Mankind Pharma

Acquired Company

Bharat Serums and Vaccines Limited

New DelhiNavi MumbaiBiotechnologyHealth CarePharmaceuticalPharmaceutical

Description

Mankind Pharma will take control of Bharat Serums and Vaccines Limited's business through a voluntary liquidation process. This acquisition is valued at Rs 13,768 crore and aims at integrating BSVL's operations efficiently. The decision to pursue this method avoids the lengthy NCLT approval process normally required for mergers. The restructuring aims to enhance operational efficiency and resource utilization for Mankind Pharma.

Company Information

Company

Mankind Pharma

Location

New Delhi, Delhi, India

About

Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. This strategic move marks a significant leap for the company, positioning it as a market leader in the Indian women's health and fertility drug market alongside access to other high entry barrier products in the critical care segment with established complex R&D tech platforms.

Don't miss Mankind Pharma's next move

Get an email the moment Mankind Pharma makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Vijay
Likely contact at this company
••••••••@••••••••

See Vijay's verified email →

Divya
Likely contact at this company
••••••••@••••••••

See Divya's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Mankind Pharma's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Bharat Serums and Vaccines Limited?

Bharat Serums and Vaccines Limited was acquired by Mankind Pharma, based in New Delhi. The deal was reported on September 13, 2026. Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. Mankind Pharma is privately held and operates in Biotechnology.

When did Mankind Pharma acquire Bharat Serums and Vaccines Limited?

Mankind Pharma's acquisition of Bharat Serums and Vaccines Limited was reported on September 13, 2026. Mankind Pharma will take control of Bharat Serums and Vaccines Limited's business through a voluntary liquidation process. This acquisition is valued at Rs 13,768 crore and aims at integrating BSVL's operations efficiently. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Bharat Serums and Vaccines Limited do?

Bharat Serums and Vaccines Limited (BSV) is a wholly owned subsidiary specializing in vaccines and biopharmaceuticals. The company works towards the development and manufacture of a range of healthcare products. It is privately held, operating in Pharmaceutical, and is based in Navi Mumbai.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.